Showing 1 - 5 results of 5 for search 'Julie Birt', query time: 0.03s Refine Results
  1. 1
    Letter to the Editor: Response to Fitzgerald T et al. Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA

    Letter to the Editor: Response to Fitzgerald T et al. Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA by Andrew Blauvelt, Alyssa Garrelts, William Malatestinic, Julie Birt, Baojin Zhu, Meghan Feely

    Published 2023-09-01
    Get full text
    Article
  2. 2
    Patient Perspective on the Burden of Skin and Joint Symptoms of Psoriatic Arthritis: Results of a Multi-National Patient Survey

    Patient Perspective on the Burden of Skin and Joint Symptoms of Psoriatic Arthritis: Results of a Multi-National Patient Survey by Joseph F. Merola, David Shrom, Jennifer Eaton, Christine Dworkin, Craig Krebsbach, Bijal Shah-Manek, Julie Birt

    Published 2019-01-01
    Get full text
    Article
  3. 3
    Changes in musculoskeletal disease activity and patient-reported outcomes in patients with psoriatic arthritis treated with ixekizumab: results from a real-world US cohort

    Changes in musculoskeletal disease activity and patient-reported outcomes in patients with psoriatic arthritis treated with ixekizumab: results from a real-world US cohort by William Tillett, Julie Birt, Cristi Cavanaugh, Yoojin Jung, Aisha Vadhariya, Sarah Ross, Jessica Paulus, Ennio Lubrano

    Published 2023-06-01
    Get full text
    Article
  4. 4
    Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower

    Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower by W. Benjamin Nowell, Kelly Gavigan, Carol L. Kannowski, Zhihong Cai, Theresa Hunter, Shilpa Venkatachalam, Julie Birt, Jennifer Workman, Jeffrey R. Curtis

    Published 2021-02-01
    Get full text
    Article
  5. 5
    Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis

    Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis by Dafna D. Gladman, Ana-Maria Orbai, Uta Klitz, James Cheng-Chung Wei, Gaia Gallo, Julie Birt, Suchitrita Rathmann, David Shrom, Helena Marzo-Ortega

    Published 2019-01-01
    Get full text
    Article

Search Tools: